Apimeds Pharmaceuticals US Inc （APUS）
$5.04 +120.09% (MktCap: 7.62M)
wow.qtsky.com/stocksearch/APUS
Surrozen Inc （SRZN）
$33.68 +108.42% (MktCap: 395.87M)
wow.qtsky.com/stocksearch/SRZN
Greenland Energy Co （GLND）
$5.33 +83.16% (MktCap: 233.07M)
wow.qtsky.com/stocksearch/GLND
Profusa Inc （PFSA）
$3.03 +47.80% (MktCap: 1.83M)
wow.qtsky.com/stocksearch/PFSA
YD Bio Ltd （YDES）
$4.77 +47.68% (MktCap: 337.92M)
wow.qtsky.com/stocksearch/YDES
Hang Feng Technology Innovation Co Ltd （FOFO）
$2.43 +38.07% (MktCap: 28.12M)
wow.qtsky.com/stocksearch/FOFO
Springview Holdings Ltd （SPHL）
$3.13 +35.73% (MktCap: 38.39M)
wow.qtsky.com/stocksearch/SPHL
Greenland Mines Ltd （GRML）
$14.89 +33.07% (MktCap: 47.3M)
wow.qtsky.com/stocksearch/GRML
AVAX One Technology Ltd （AVX）
$5.45 +32.93% (MktCap: 40.32M)
wow.qtsky.com/stocksearch/AVX
Wetour Robotics Ltd （WETO）
$1.9 +31.03% (MktCap: 2.04M)
wow.qtsky.com/stocksearch/WETO
========================
Apimeds Pharmaceuticals US Inc (APUS)$5.04+120.09%
wow.qtsky.com/stocksearch/APUS
Apimeds Pharmaceuticals US, Inc. (APUS) is experiencing a drastic surge today, primarily driven by a significant technology services agreement rather than a simple analyst coverage initiation. The stock has rocketed upwards by over 145% on September 24, 2026, with trading volume exploding to over 69 million shares, significantly above its average. This substantial volatility follows a 1-for-10 reverse stock split executed on September 22, 2026, which reset its per-share price higher but did not change the company's overall market capitalization.
The core reason for today's sharp upward movement stems from an announcement that Apimeds' wholly-owned subsidiary, MindWave Innovations Inc., has signed a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. to develop and operate "AQUAEChain," a platform for insured ALCI Credits. Under this agreement, MindWave will earn service fees and a recurring 20% allocation of all issued ALCI Credits quarterly, with an option for a five-year extension. This news has ignited aggressive momentum trading, creating a short-squeeze-like scenario as traders target the volatile breakout.
Despite this surge, APUS remains a highly speculative stock, characterized by deep losses and negative cash flow, with quarterly net income around -$20.2 million. The company's primary business is developing Apitox, a bee venom-based drug for knee osteoarthritis, while MindWave represents its digital asset integration.
========================
Surrozen Inc (SRZN)$33.68+108.42%
wow.qtsky.com/stocksearch/SRZN
Surrozen (NASDAQ:SRZN) experienced a significant surge in its stock price today, primarily driven by the company's announcement of submitting an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for SZN-8141. This investigational therapy is intended for the treatment of diabetic macular edema (DME). The stock price rose sharply, with shares reported to be up 98.45% to $32.07 at the time of publication on Thursday.
Surrozen is a clinical-stage biotechnology company focused on developing therapeutics that harness Wnt signaling, a critical pathway for tissue repair, particularly for sight-threatening ophthalmic conditions. The SZN-8141 program is notable for its novel dual-mechanism approach, combining Wnt pathway activation with VEGF inhibition within a single molecule, aiming to address both vascular leakage and retinal vascular health. The successful submission of the IND application signifies a crucial step forward, potentially allowing the company to advance its lead therapy into clinical trials.
The reference news headline "SRZN Options Chain — NASDAQ:SRZN" is highly pertinent, as such a substantial price movement inevitably fuels increased activity and interest in the company's options market. The implied volatility for SRZN currently stands at a very high 95.8, placing it in the 100th percentile rank for the last year, indicating market expectations of continued high future volatility. While Surrozen also has a notable short interest, with 18.24% of its float shorted and a days-to-cover ratio of 7.73, the primary catalyst for today's dramatic upward movement is the positive regulatory news regarding its promising therapeutic candidate, rather than a short squeeze as the initial core driver.
========================
Greenland Energy Co (GLND)$5.33+83.16%
wow.qtsky.com/stocksearch/GLND
Greenland Energy (GLND) stock experienced a significant surge today, primarily driven by the announcement of an extended farm-out agreement with 80 Mile plc. The company confirmed an amendment to their existing agreement for two exploration wells in East Greenland's Jameson Land Basin, which saw its stock price jump by 67%. Specifically, the longstop dates for both exploration wells have been extended, with one pushed back two years to the end of 2028 and the other by one year to the end of 2027 (or both to December 31, 2028, according to some reports).
This extension is crucial for GLND, an exploration-stage oil and gas company with no current revenue, as it provides valuable additional time to advance the permitting process for its drilling program. Investors have viewed this development positively as it reduces near-term execution risk and signals continued commitment to the project. Under the revised terms, Greenland Energy will now bear sole responsibility for securing and maintaining the necessary permits and approvals, at its own cost, and will pay 80 Mile a fee of £500,000. Additionally, the stock had seen previous gains earlier in the week due to broader market interest in Greenland-linked stocks following a new U.S.-Denmark-Greenland security agreement. The unusually high options trading volume for GLND also suggests increased speculative interest.
========================
Profusa Inc (PFSA)$3.03+47.80%
wow.qtsky.com/stocksearch/PFSA
Profusa Inc. (PFSA) is experiencing significant upward volatility today, primarily driven by a positive regulatory announcement. The company disclosed that it received a favorable decision from GMED regarding the ISO 13485 certification for its quality management system, a crucial step towards obtaining the CE Mark for its Lumee® Oxygen Platform in the European Union. This news acts as a strong catalyst, propelling the stock higher, with premarket trading seeing surges over 70% and intraday gains exceeding 50%.
While the provided news headline mentions shareholders endorsing a reverse stock split authorization, this is a background factor reflecting the company's persistent efforts to maintain Nasdaq listing compliance, having undergone multiple reverse splits in 2026 (1-for-75 in February, 1-for-25 in July, and 1-for-4 in August). Reverse splits are typically a sign of financial distress and share price erosion, often leading to negative market sentiment. However, today's surge is directly attributable to the specific positive regulatory development, which signals a potential pathway to commercialization and revenue in the EU, rather than financial restructuring actions. The company continues to face "extremely weak financial performance" with negative equity and no revenue, rendering it a "highly speculative" trading vehicle.
========================
YD Bio Ltd (YDES)$4.77+47.68%
wow.qtsky.com/stocksearch/YDES
YD Bio (YDES) is experiencing significant volatility, including its movements today, primarily due to prevailing concerns regarding its financial viability rather than the recently published peer-reviewed article in "Nutrients." While the August 25, 2026, announcement of the publication, co-authored with physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute, is a positive development for its nutraceutical initiatives and scientific credibility, its impact on the stock's substantial fluctuations has been overshadowed by more pressing financial issues.
The core reason for the stock's volatility stems from the unaudited financial results for the six months ended June 30, 2026, released on August 31, 2026. Despite reporting a net income of $6.7 million and a 315% surge in top-line revenue, the company explicitly issued a "going concern" warning, indicating substantial doubt about its ability to continue operations without additional financing. Crucially, the reported net income was primarily driven by a non-cash gain of $9.8 million from the change in fair value of warrant liabilities, masking an underlying operating loss of $3.23 million and a decline in cash reserves.
This stark contrast between reported "profitability" and the "going concern" warning creates deep investor uncertainty. While CEO Dr. Ethan Shen made insider purchases in early and mid-September, these signals of confidence have not been sufficient to counteract the broader financial anxieties. The stock, trading in a wide 52-week range of $1.70 to $22.00 and down significantly over the past year, is inherently speculative. There is no strong evidence of a short squeeze being the primary driver of today's movements, as short interest data is either unavailable or relatively low. Therefore, YDES's large intraday swings reflect the high-risk nature of a biotechnology firm facing significant operational cash burn and the critical need for external funding to sustain its long-term strategy.
========================
Hang Feng Technology Innovation Co Ltd (FOFO)$2.43+38.07%
wow.qtsky.com/stocksearch/FOFO
Hang Feng Technology Innovation Co., Ltd. (NASDAQ: FOFO) is currently experiencing significant downward pressure, with its recent dramatic fluctuations primarily driven by severely disappointing financial results for the first half of 2026. The company announced on September 8, 2026, a sharp decline in revenue and a swing to a net loss for the six months ended June 30, 2026. Specifically, total revenue plummeted to $362,511 from $1,327,707 in the first half of 2025, and the company reported a net loss of $553,033, a stark contrast to the net income of $363,524 a year earlier.
Management attributed this substantial deterioration in performance largely to the reallocation of resources towards Real World Asset (RWA) initiatives, which consequently reduced revenue from their traditional corporate management consulting services. This strategic pivot, while potentially positioning the company for future growth in digital assets, is clearly impacting its near-term financial stability and profitability. The market's negative reaction has been sustained, as evidenced by the stock hitting an all-time low of $1.70 on September 17, 2026, and trading significantly down from its 52-week high of $68.00. Today's volatility is therefore a continuation of the market's ongoing digestion of these poor financial results and concerns surrounding the company's strategic transition, rather than a new, isolated catalyst.
========================
Springview Holdings Ltd (SPHL)$3.13+35.73%
wow.qtsky.com/stocksearch/SPHL
SPHL (Springview Holdings) has experienced significant volatility today primarily due to the release of its unaudited interim results for the six months ended June 30, 2026, on September 23, 2026. The financial report showed a 38.4% increase in revenue to S$5.17 million and a narrowed net loss of 38.0% to S$0.315 million, compared to the previous year. While revenue growth and a smaller loss are positive signs, the company remains unprofitable, reported increased cash usage in operations, and a declining cash balance.
This mixed financial picture, combined with SPHL's characteristics as a small-cap stock with a limited float, has fueled intense speculative trading. The stock exhibited "textbook parabolic action," surging from the low-$3s to an intraday high near $5.77, only to pull back sharply into the $3s and then the $2s, attracting day traders and momentum players. Despite a premium valuation (price-to-sales near 4.4 and price-to-book above 5), the company still shows negative returns on invested capital, suggesting that current price movements are driven more by market sentiment and short-term trading dynamics than by robust fundamental improvements. Regulatory issues or a short squeeze do not appear to be the primary drivers of today's sharp fluctuation.
========================
Greenland Mines Ltd (GRML)$14.89+33.07%
wow.qtsky.com/stocksearch/GRML
Greenland Mines Ltd. (GRML) has experienced significant volatility and upward movement recently, with today's substantial fluctuation primarily driven by its successful equity financing. On September 24, 2026, the company announced it completed a $12-per-share equity financing, raising $42 million to fully fund its planned exploration and development programs through 2027. This crucial capital infusion, priced at a premium to the previous day's close, immediately boosted investor confidence and sent shares surging over 20% in pre-market trading.
This financing event builds on a series of positive catalysts earlier in the week. The most significant was the U.S.-Denmark-Greenland security agreement announced around September 18, which reduced geopolitical risk for Greenlandic resource projects and aimed to secure Western supply chains for critical minerals. This pact, perceived to favor Western-aligned developers like GRML, ignited a multi-day rally for the stock. Concurrently, on September 21, Greenland Mines applied to more than double its rare-earth mining footprint in West Greenland, expanding its Sarfartoq project to a "district scale." This strategic expansion and the impressive initial assessment for Sarfartoq, outlining a high-case pre-tax NPV of up to $2.05 billion, further fueled investor enthusiasm. The combination of geopolitical tailwinds, strategic operational expansion, and strengthened financial position are the core reasons behind GRML's recent dramatic share price appreciation and today's significant upward movement.
========================
AVAX One Technology Ltd (AVX)$5.45+32.93%
wow.qtsky.com/stocksearch/AVX
AVAX One Technology Ltd. (NASDAQ: AVX) has experienced a significant upward fluctuation today, increasing by over 13% in the past 24 hours. This volatility is likely driven by a confluence of recent positive corporate actions and renewed investor interest in its specialized business model.
A primary catalyst for the stock's recent strength appears to be the company's ongoing $40 million share repurchase program, with an update on September 2, 2026, confirming the buyback of 85,724 common shares since June 30, 2026, at an average price of $4.28. This signals strong management confidence and reduces the outstanding share count, often seen as a bullish indicator.
Furthermore, earlier positive developments from August 2026 likely continue to underpin investor sentiment. These include the successful restructuring of a convertible debt facility, which strengthened the company's balance sheet, and its regaining compliance with Nasdaq's $1.00 minimum bid price requirement in July 2026, mitigating delisting risks. Although the Q2 2026 earnings reported a net loss primarily due to non-cash digital asset write-downs, the substantial revenue growth from Avalanche staking and Bitcoin mining may be attracting investors focused on operational performance in the digital asset space.
The company's strategic focus on digital infrastructure for AI, high-performance computing, and its Avalanche token treasury aligns with high-growth sectors, potentially attracting speculative capital. The increased trading volume seen on September 23, 2026, also suggests a surge in market activity, which could further fuel price momentum. While no explicit short squeeze information is available, the stock's high volatility (beta 2.22) combined with these positive catalysts could contribute to such dynamics.
========================
Wetour Robotics Ltd (WETO)$1.9+31.03%
wow.qtsky.com/stocksearch/WETO
Wetour Robotics (WETO) experienced significant volatility today, with shares declining during regular trading hours before a substantial after-hours rally. The core reason for this fluctuation stems from the company's recent strategic announcement: the launch of Vantrapower LLC on September 17, 2026. This new subsidiary is focused on intelligent power infrastructure for AI industrial and energy markets in Texas and North America, including transformer supply for data centers and energy storage projects. This expansion is seen as a pivotal move to reposition the company as an AI infrastructure and automation integrator, driving heightened investor interest and speculative buying.
The stock’s movement is also influenced by its highly speculative nature and historical price action. WETO has a very low market capitalization (around $1.56-$1.92 million) and has suffered a severe decline of over 99% in the past year, with a 52-week high of $251.00 and a low of $1.45. Despite reporting approximately $35.6 million in annual revenue, it trades at very low price-to-sales (0.34) and price-to-book (0.21) ratios, indicating a deep market discount. Furthermore, the company faces liquidity concerns with roughly $12.2 million in cash against about $30 million in short-term debt. An increase in short interest (up 475.6% from the previous period to 35,047 shares) may also contribute to amplified price movements, potentially leading to short-covering rallies in response to positive news. The positive news about Vantrapower likely triggered a "relief bounce" or short squeeze in a heavily beaten-down stock.
========================
For daily analysis of top US stock market losers visit:
https://bigmovewhy.qtsky.com/us-stocks
--------------------------------------------------------
BigMoveWhy-BMW is powered by WOW!StockSearch
Tech Development by QTsky (Build your own tools)
https://wow.qtsky.com
